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Background
Post Haemorrhagic Hydrocephalus (PHH) secondary to
Neonatal Intraventricular Haemorrhage (IVH) is the com-
monest cause of infantile hydrocephalus. The presence of
ventricular blood, underdeveloped immune systems and
thin, friable skin preclude shunting as a primary interven-
tion. Studies show that serial lumbar punctures, medical
management and ventricular taps have no discernible
effect on outcome. This study attempts to more clearly
elucidate the role and efficacy of ventricular access devices
(VAD) in the treatment of PHH. The aims were to deter-
mine the complication rate, the use of the VAD and the
number of patients with VAD who later required shunt-
ing.
Materials and methods
29 Neonates were identified from the Leeds General Infir-
mary (LGI) database from 1999 to 2005 who underwent
VAD insertion. A retrospective review of the notes from
the LGI and the referring hospitals during the period of
VAD insertion was undertaken.
Results
Complication rate was 12% with two wound breakdowns
and one cardiorespiratory arrest. 62% required a shunt,
71% of whom had a birth weight of less than 1 Kg and
78% were born at less than 27 weeks. The shunted
patients had their VAD accessed far more frequently than
the non-shunted group. There was an average of 10.4 taps
per shunted patient. 24/29 utilised the VAD regularly, but
there was poor documentation of opening and closing
pressures, ventricular indices and head circumference
both pre and post tapping. 10/29 utilised VAD but did not
require shunting, it is equivocal whether maturation
would have taken place regardless of the VAD. There is a
direct association between frequent use of the VAD and
shunting suggesting a useful treatment tool with minimal
complications.
Conclusion
The low complication rate associated with VAD suggests
that they should be the intervention of choice in neonates
with PHH. The role of the VAD is to 'buy time' allowing
the patient to mature to a sufficient size prior to shunt
insertion and to distinguish the group of patients with
progressive PHH from those that will not require shunt
placement. It is additionally recommended that more vig-
ilance over documentation of VAD utilisation needs to be
adhered to by the neonatal team.
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